WHO ICTRP trial
A randomised controlled trial of colorectal polyp and cancer prevention using…
ISRCTN59521990 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN59521990 |
|---|---|
| Public title | A randomised controlled trial of colorectal polyp and cancer prevention using aspirin and resistant starch in carriers of hereditary nonpolyposis colorectal cancer |
| Scientific title | A randomised controlled trial of colorectal polyp and cancer prevention using aspirin and resistant starch in carriers of hereditary nonpolyposis colorectal cancer |
| Primary sponsor | Newcastle upon Tyne Hospitals NHS Trust (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom |
| Conditions | Hereditary non-polyposis colorectal cancer (HNPCC) Cancer Malignant neoplasm of colon |
| Interventions | Targets Lynch syndrome patients/600 mg enteric coated aspirin daily or placebo AND 30 g resistant starch or placebo: 1. 600 mg aspirin/30 g treatment starch 2. 600 mg placebo tablets/30 g treatment starch 3. 600 mg aspirin/30 g placebo… |
| Registration date | May 18, 2001 |
| Target size | 1000 |
| Secondary IDs | G0100496 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: